The Competition Commission, in its meeting on 01.07.2024, considered the case of concentration obtained through the acquisition of joint control of the undertaking MEGAPHARMA LLC from the undertakings T-MEDSS LLC, Mr. Robert Çina and Mrs. Monika Hamzaraj.
As a result of this transaction, there will be no overlap between the parties’ activities (buyer and target) in the retail pharmaceuticals market at the national level and for these reasons, the intended transaction will not bring change and will not have an impact on the market structures.
For these reasons, the Competition Commission by Decision no. 1090, dated 01.07.2024, decided to authorize the concentration obtained through the acquisition of joint control of the undertaking MEGAPHARMA LLC from the undertaking T-MEDSS LLC, Mr. Robert Çina and Mrs. Monika Hamzaraj.
In addition, please consult the official website of the Competition Authority at http://caa.gov.al.